![Sung Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sung Lee
Director of Finance/CFO at
CYTOKINETICS, INCORPORATED
Net worth: 5 M $ as of 30/05/2026
Profile
Sung H.
Lee is currently Lead Independent Director at Tango Therapeutics, Inc. since 2026 and Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. since 2024.
Former positions include Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2023 to 2024, Chief Financial Officer at MorphoSys AG from 2021 to 2023, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, and Vice President-Investor Relations at Gilead Sciences, Inc. from 2016 to 2019.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Irvine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/05/2026 | 63,221 ( 0.05% ) | 5 M $ | 30/05/2026 | |
| 04/06/2026 | 22,870 ( 0.02% ) | 502 683 $ | 30/05/2026 |
Sung Lee active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director of Finance/CFO | 07/05/2024 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | 04/01/2026 |
Former positions of Sung Lee
| Companies | Position | End |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director of Finance/CFO | 02/05/2024 |
| MORPHOSYS AG | Director of Finance/CFO | 16/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 31/01/2021 |
| GILEAD SCIENCES, INC. | Investor Relations Contact | 30/10/2019 |
Training of Sung Lee
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
- Stock Market
- Insiders
- Sung Lee
